{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:02:00Z","timestamp":1790949720795,"version":"4.1.0"},"reference-count":25,"publisher":"Texas Heart Institute Journal","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"abstract":"Glucose-6-phosphate dehydrogenase (G6PD) protects erythrocytes from oxidative stress and hemolysis; G6PD deficiency is the most prevalent enzymopathy. The United States military routinely performs tests to prevent exposing G6PD-deficient personnel to antimalarial drugs that might cause life-threatening hemolytic reactions. In addition, G6PD is a key determinant of vascular function, and its deficiency can lead to impaired nitric oxide production and greater vascular oxidant stress\u2014precursors to atherosclerosis and cardiovascular disease. Using military medical records, we performed a retrospective, cross-sectional study to investigate whether deficient G6PD levels are associated with a higher prevalence of cardiovascular disease than are normal levels, and, if so, whether the relationship is independent of accepted cardiovascular risk factors.<\/jats:p>\n We analyzed the medical records of 737 individuals who had deficient G6PD levels and 16,601 who had normal levels. Everyone had been screened at U.S. military medical centers from August 2004 through December 2007. We evaluated our dependent variable (composite cardiovascular disease) at the individual level, and performed binary logistic regression of our independent variable (G6PD status) and control variables (modifiable cardiovascular risk factors). The adjusted odds ratio of 1.396 (95% CI, 1.044\u20131.867; P<\/jats:italic> <0.05) indicated that G6PD-deficient individuals have 39.6% greater odds of developing cardiovascular disease than do those with normal levels.<\/jats:p>\n Early intervention may reduce the incidence of cardiovascular disease in military personnel and civilians who have deficient G6DP levels.<\/jats:p>","DOI":"10.14503\/thij-16-6052","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T18:22:58Z","timestamp":1532456578000},"page":"144-150","source":"Crossref","is-referenced-by-count":44,"title":["Glucose-6-Phosphate Dehydrogenase Deficiency is Associated with Cardiovascular Disease in U.S. Military Centers"],"prefix":"10.14503","volume":"45","author":[{"given":"John E.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungho","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forest S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. David","family":"Mangelsdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred K.","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5628","reference":[{"key":"i1526-6702-45-3-144-b1","series-title":"Nathan and Oski's hematology of infancy and childhood","first-page":"883","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"Vol. 1","year":"2009","unstructured":"Luzzatto\n L\n , PoggiV.\n Glucose-6-phosphate dehydrogenase deficiency. In: OrkinSH, NathanDG, GinsburgD, LookAT, FisherDE, LuxSE, editors. Nathan and Oski's hematology of infancy and childhood. 7th ed. Vol. 1. Philadelphia: Saunders Elsevier; 2009. p. 883\u2013907."},{"issue":"10","key":"i1526-6702-45-3-144-b2","series-title":"Circulation","first-page":"e120","article-title":"Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Basic Science Writing Group","volume":"111","year":"2005","unstructured":"Benjamin\n IJ\n , ArnettDK, LoscalzoJ; American Heart Association Basic Science Writing Group. \n Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Basic Science Writing Group. Circulation2005;111(10):e120\u20133."},{"issue":"4","key":"i1526-6702-45-3-144-b3","series-title":"N Engl J Med","first-page":"321","article-title":"Lifetime risks of cardiovascular disease","volume":"366","year":"2012","unstructured":"Berry\n JD\n , DyerA, CaiX, GarsideDB, NingH, ThomasA, \n et al. Lifetime risks of cardiovascular disease. N Engl J Med2012;366(4):321\u20139."},{"issue":"1","key":"i1526-6702-45-3-144-b4","series-title":"Am J Hum Genet","first-page":"35","article-title":"Associations between red cell glucose-6-phosphate dehydrogenase variants and vascular diseases","volume":"19","year":"1967","unstructured":"Long\n WK\n , WilsonSW, FrenkelEP.\n Associations between red cell glucose-6-phosphate dehydrogenase variants and vascular diseases. Am J Hum Genet1967;19(1):35\u201353."},{"issue":"4","key":"i1526-6702-45-3-144-b5","series-title":"Am J Physiol Heart Circ Physiol","first-page":"H491","article-title":"Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease","volume":"304","year":"2013","unstructured":"Hecker\n PA\n , LeopoldJA, GupteSA, RecchiaFA, StanleyWC.\n Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. Am J Physiol Heart Circ Physiol2013;304(4):H491\u2013500."},{"issue":"9147","key":"i1526-6702-45-3-144-b6","series-title":"Lancet","first-page":"89","article-title":"Lifetime risk of developing coronary heart disease","volume":"353","year":"1999","unstructured":"Lloyd-Jones\n DM\n , LarsonMG, BeiserA, LevyD.\n Lifetime risk of developing coronary heart disease. Lancet1999;353(9147):89\u201392."},{"issue":"9349","key":"i1526-6702-45-3-144-b7","series-title":"Lancet","first-page":"1903","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","year":"2002","unstructured":"Lewington\n S\n , ClarkeR, QizilbashN, PetoR, CollinsR; \n Prospective Studies Collaboration [published erratum appears in Lancet 2003;361(9362):1060]. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet2002;360(9349):1903\u201313."},{"issue":"9932","key":"i1526-6702-45-3-144-b8","series-title":"Lancet","first-page":"1899","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people","volume":"383","year":"2014","unstructured":"Rapsomaniki\n E\n , TimmisA, GeorgeJ, Pujades-RodriguezM, ShahAD, DenaxasS, \n et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet2014;383(9932):1899\u2013911."},{"issue":"3","key":"i1526-6702-45-3-144-b9","series-title":"Atherosclerosis","first-page":"451","article-title":"Cigarette smoking and atherosclerosis in autopsied men","volume":"23","year":"1976","unstructured":"Strong\n JP\n , RichardsML.\n Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis1976;23(3):451\u201376."},{"issue":"6","key":"i1526-6702-45-3-144-b10","series-title":"Circulation","first-page":"2025","article-title":"Familial lipoprotein disorders in patients with premature coronary artery disease","volume":"85","year":"1992","unstructured":"Genest\n JJ\n Jr\n , Martin-MunleySS, McNamaraJR, OrdovasJM, JennerJ, MyersRH, \n et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation1992;85(6):2025\u201333."},{"issue":"1","key":"i1526-6702-45-3-144-b11","series-title":"Circulation","first-page":"8","article-title":"Diabetes and cardiovascular risk factors: the Framingham study","volume":"59","year":"1979","unstructured":"Kannel\n WB\n , McGeeDL.\n Diabetes and cardiovascular risk factors: the Framingham study. Circulation1979;59(1):8\u201313."},{"issue":"1","key":"i1526-6702-45-3-144-b12","series-title":"J Am Coll Cardiol","first-page":"65","article-title":"Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus","volume":"47","year":"2006","unstructured":"Scognamiglio\n R\n , NegutC, RamondoA, TiengoA, AvogaroA.\n Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol2006;47(1):65\u201371."},{"issue":"3220","key":"i1526-6702-45-3-144-b13","series-title":"Science","first-page":"484","article-title":"Enzymatic deficiency in primaquine-sensitive erythrocytes","volume":"124","year":"1956","unstructured":"Alving\n AS\n , CarsonPE, FlanaganCL, IckesCE.\n Enzymatic deficiency in primaquine-sensitive erythrocytes. Science1956;124(3220):484\u20135."},{"key":"i1526-6702-45-3-144-b14","article-title":"Traveler's health. Special considerations for military deployments","unstructured":"Fukuda\n M\n , RaczniakGA, RiddleMS, ForgioneM, MagillAJ; Centers for Disease Control and Prevention. \n Traveler's health. Special considerations for military deployments. Available from: http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2014\/chapter-8-advising-travelers-with-specific-needs\/special-considerations-for-us-military-deployments [2013; cited 2014 Jan 15]."},{"issue":"9","key":"i1526-6702-45-3-144-b15","series-title":"Mil Med","first-page":"905","article-title":"Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel","volume":"171","year":"2006","unstructured":"Chinevere\n TD\n , MurrayCK, GrantEJr, JohnsonGA, DuelmF, HospenthalDR.\n Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel. Mil Med2006;171(9):905\u20137."},{"issue":"2","key":"i1526-6702-45-3-144-b16","series-title":"Blood","first-page":"706","article-title":"Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency","volume":"91","year":"1998","unstructured":"Cocco\n P\n , ToddeP, ForneraS, MancaMB, MancaP, SiasAR.\n Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency. Blood1998;91(2):706\u20139."},{"key":"i1526-6702-45-3-144-b17","series-title":"Clinical studies in medical biochemistry","first-page":"123","article-title":"Glucose 6-phosphate dehydrogenase deficiency and oxidative hemolysis","year":"2007","unstructured":"Burton\n C\n , KaczmarskiR.\n Glucose 6-phosphate dehydrogenase deficiency and oxidative hemolysis. In: GlewRH, RosenthalMD, editors. Clinical studies in medical biochemistry. New York: Oxford University Press, Inc.; 2007. p. 123\u201333."},{"key":"i1526-6702-45-3-144-b18","article-title":"Standardization of procedures for the study of glucose-6-phosphate dehydrogenase: report of a WHO Scientific Group","year":"1967","unstructured":"World Health Organization. \n Standardization of procedures for the study of glucose-6-phosphate dehydrogenase: report of a WHO Scientific Group; 1967[meeting in Geneva, 5\u201310 December 1966]. Available from: http:\/\/apps.who.int\/iris\/handle\/10665\/40660."},{"issue":"8 Pt 2","key":"i1526-6702-45-3-144-b19","series-title":"Clin Chem","first-page":"1809","article-title":"Role of nitric oxide in cardiovascular disease: focus on the endothelium [published erratum appears in Clin Chem 1998;44(9):2070]","volume":"44","year":"1998","unstructured":"Cannon\n RO\n 3rd.\n \n \n Role of nitric oxide in cardiovascular disease: focus on the endothelium [published erratum appears in Clin Chem 1998;44(9):2070]. Clin Chem1998;44(8 Pt 2):1809\u201319."},{"issue":"3","key":"i1526-6702-45-3-144-b20","series-title":"Vasc Health Risk Manag","first-page":"183","article-title":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome","volume":"1","year":"2005","unstructured":"Hadi\n HA\n , CarrCS, Al SuwaidiJ.\n Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag2005;1(3):183\u201398."},{"issue":"10","key":"i1526-6702-45-3-144-b21","series-title":"Circ Res","first-page":"840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","year":"2000","unstructured":"Cai\n H\n , HarrisonDG.\n Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res2000;87(10):840\u20134."},{"issue":"6","key":"i1526-6702-45-3-144-b22","series-title":"Circulation","first-page":"653","article-title":"Prognostic value of coronary vascular endothelial dysfunction","volume":"106","year":"2002","unstructured":"Halcox\n JP\n , SchenkeWH, ZalosG, MincemoyerR, PrasadA, WaclawiwMA, \n et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation2002;106(6):653\u20138."},{"issue":"10","key":"i1526-6702-45-3-144-b23","series-title":"FASEB J","first-page":"1771","article-title":"Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability","volume":"15","year":"2001","unstructured":"Leopold\n JA\n , CapA, ScribnerAW, StantonRC, LoscalzoJ.\n Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J2001;15(10):1771\u20133."},{"issue":"25","key":"i1526-6702-45-3-144-b24","series-title":"Circulation","first-page":"3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation2002;106(25):3143\u2013421."},{"issue":"19","key":"i1526-6702-45-3-144-b25","series-title":"JAMA","first-page":"2120","article-title":"Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction","volume":"306","year":"2011","unstructured":"Canto\n JG\n , KiefeCI, RogersWJ, PetersonED, FrederickPD, FrenchWJ, \n et al. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA2011;306(19):2120\u20137."}],"container-title":["Texas Heart Institute Journal"],"original-title":[],"link":[{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/45\/3\/article-p144.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/thij\/article-pdf\/45\/3\/144\/1972452\/thij-16-6052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/45\/3\/article-p144.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/45\/3\/article-p144.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T15:36:34Z","timestamp":1730993794000},"score":1,"resource":{"primary":{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/45\/3\/article-p144.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":25,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.14503\/thij-16-6052","relation":{},"ISSN":["0730-2347","1526-6702"],"issn-type":[{"value":"0730-2347","type":"print"},{"value":"1526-6702","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}